Susan Doleman
Director Técnico/Científico/I+D en CYTEIR THERAPEUTICS, INC. .
Origen de la red de primer grado Susan Doleman.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Biotechnology | 20 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Susan Doleman a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Public Communications Contact Corporate Officer/Principal | |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto. | Investment Managers | Private Equity Investor | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director of Finance/CFO | |
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Pharmaceuticals: Major | Chairman | |
| ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Director/Board Member Compliance Officer | |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member | |
| ATHIRA PHARMA, INC. | Biotechnology | Director of Finance/CFO | |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Analyst | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
| New York University | College/University | Graduate Degree Masters Business Admin | |
| St. Joseph's University | College/University | Masters Business Admin | |
| INSEAD | College/University | Masters Business Admin | |
| Katholieke Universiteit Leuven | College/University | Undergraduate Degree | |
Easton Associates LLC
 Easton Associates LLC Miscellaneous Commercial ServicesCommercial Services Part of Guidehouse LLP, Easton Associates LLC is a management consulting company that provides services to the healthcare industry. The company is based in New York, NY. The company was founded by Robert J. Easton, Michelle Hasson. Easton Associates was acquired by Guidehouse, Inc. (Virginia), part of Guidehouse LLP from October 11, 2019 on October 02, 2012 for $12.10 million. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Waterland Private Equity NV | Investment Managers | Private Equity Investor | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member | |
| COGNITION THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Essential Access Health
 Essential Access Health Medical/Nursing ServicesHealth Services Essential Access Health provides family healthcare services. Its services include clinic support initiatives, advanced clinical research, provider training, patient education, advocacy, and consumer awareness. The company was founded in 1968 and is headquartered in Los Angeles, CA. | Medical/Nursing Services | Director/Board Member | |
| CALITHERA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Founder | |
Cristal Delivery BV
 Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
| UCLA Anderson School of Management | College/University | Masters Business Admin | |
| PROQR THERAPEUTICS N.V. | Pharmaceuticals: Major | Investor Relations Contact | |
DROIA NV
 DROIA NV Investment ManagersFinance DROIA NV (DROIA) is an Independent Venture Capital firm founded in 2011 by Bart van Hooland. The firm is headquartered in Meise with additional office in Luxembourg. | Investment Managers | Private Equity Investor | |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Investor Relations Contact | |
Tusk Therapeutics Ltd.
 Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Tusk Therapeutics Ltd. operates as a immuno-oncology company, focused on discovering and developing therapeutic antibodies. It provides immune modulating cancer therapeutics. The company is headquartered in Stevenage, the United kingdom. | Pharmaceuticals: Major | Director/Board Member | |
OCTIMET Oncology NV
 OCTIMET Oncology NV BiotechnologyHealth Technology OCTIMET Oncology NV develops MET kinase inhibitors for the treatment of cancer. The company was founded by Timothy Perera, Ann Louise Meulemans, Paolo Comoglio, and Philip Owen in 2016 and is headquartered in Beerse, the Netherlands. | Biotechnology | Director/Board Member | |
Highlight Therapeutics SL
 Highlight Therapeutics SL Pharmaceuticals: MajorHealth Technology Highlight Therapeutics develops ribonucleic acid-based therapies and novel targets in cancer and immune cells. Its product BO-112, induces immunogenic cell death in solid tumors and simultaneously activates the innate immune system to ensure optimal antigen processing and presentation to the adaptive immune system. The company was founded by Damia tormo Carulla and is headquartered in Paterna, Spain. | Pharmaceuticals: Major | Director/Board Member | |
Convert Pharmaceuticals SA
 Convert Pharmaceuticals SA Miscellaneous Commercial ServicesCommercial Services Convert Pharmaceuticals SA provides preclinical stage drug development services. Its product hypoxia activated prodrug (HAP) is a therapeutic obstacle as it promotes the development of resistance to conventional anti-cancer treatments. The company was founded by Philippe Lambin, Nicolas Geuens, and Paul Tulcinsky on February 24, 2017 and is headquartered in Liege, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer | |
| SYNLOGIC, INC. | Biotechnology | Chief Operating Officer | |
AOBiome Therapeutics, Inc.
 AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Federation Bio, Inc.
 Federation Bio, Inc. BiotechnologyHealth Technology Federation Bio, Inc. uses microbiome therapeutics to address medical needs. The company was founded by Racquel N. Bracken, Michael Fischbach and Dylan Dodd and is headquartered in South San Francisco, CA. | Biotechnology | Founder | |
Frontier Medicines Corp.
 Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
Black Belt Therapeutics Ltd.
 Black Belt Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Black Belt Therapeutics Ltd. is a British biotechnology company. | Miscellaneous Commercial Services | Director/Board Member | |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Consultant / Advisor | |
DF II LP NV
 DF II LP NV Financial ConglomeratesFinance DF II LP NV is a private company based in Meise, Belgium. The Belgian company was founded in 2018. | Financial Conglomerates | Director/Board Member | |
| AN2 THERAPEUTICS, INC. | Biotechnology | Founder | |
Mbrace Therapeutics, Inc.
 Mbrace Therapeutics, Inc. BiotechnologyHealth Technology Mbrace Therapeutics, Inc. is an American company that specializes in antibody discovery methodology. The company's approach, called SPARTA, overcomes several challenges to generate human antibodies that can be quickly translated into clinical applications. Mbrace Therapeutics was founded by Renata Pasqualini, Isan Chen, and Wadih Arap, with Isan Chen serving as the CEO since incorporation. | Biotechnology | Director/Board Member | |
Turn Therapeutics(TM), Inc
 Turn Therapeutics(TM), Inc Medical SpecialtiesHealth Technology Turn Therapeutics(TM), Inc is a pharmaceutical and medical device organization that aims to reduce the human and economic costs of infection and skin disease. Turn Therapeutics(TM is based in Calabasas, CA. The private company's core mission is to innovate and educate in order to render disease obsolete. The company has multiple, mass market-ready, proprietary assets incorporating advanced delivery and healing technologies, including their FDA cleared product, Hexagen® wound dressing, which is non-irritating, non-cytotoxic, and non-sensitizing, as well as suitable for extended-wear. The company was founded by Bradley Burnam, who has been the CEO since incorporation. | Medical Specialties | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 37 |
| Bélgica | 7 |
| Países Bajos | 3 |
| Reino Unido | 3 |
| Irlanda | 2 |
Sectorial
| Health Technology | 31 |
| Finance | 9 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Health Services | 2 |
Operativa
| Director/Board Member | 97 |
| Corporate Officer/Principal | 34 |
| Independent Dir/Board Member | 29 |
| Undergraduate Degree | 17 |
| Chief Tech/Sci/R&D Officer | 13 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Jean George | 33 |
| Joseph Zakrzewski | 30 |
| Susan Molineaux | 17 |
| Karen Ho Hong | 16 |
| Stephen Sands | 15 |
| Andrew Gengos | 15 |
| Janwillem Naesens | 14 |
| John Thero | 11 |
| Jeffrey Humphrey | 8 |
| Racquel Bracken | 8 |
| Lisa A. Hayes | 7 |
| Markus Renschler | 7 |
| Timothy Romberger | 6 |
| Adam Veness | 6 |
| Paul Secrist | 5 |
- Bolsa de valores
- Insiders
- Susan Doleman
- Conexiones Empresas
